March 2026

A recent prospective case study revealed that 80 % of „No-Option“ patients can avoid amputation thanks to our minimally invasive TTT-Treatment (Transverse Tibia Transport).

„[...] Among the demographic characteristics, the average age was 
65,5 years old and 56,25% were male. Previous amputation was 
present in 93,3% of the cases, comorbidities in 93,3%, previous 
osteomyelitis in 100%, Wagner classification average grade was 
3,92 (SD 0,47), and complications during treatment in 26,7% of the 
cases. Regarding the primary outcome, 20% (N= 3/15) of the cases 
progressed to major amputation. Regarding the secondary outcome, 
80% (N=12/15) of the cases had improvement in collateral circulation.“

🔗 source: Rodrigues FL, França GUS, Silva JB, Lima LN, Furst RVC, Fornitano ALP, Lolli G, Correa JA. Tibial cortex transverse transport: a promising alternative for critic ischemic infrapatellar lesions. J Hum Growth Dev. 2025; 35(3):476-485. 
DOI: https://lnkd.in/dVkWgrZz

We at Cybion have always believed in the TTT-Technique. We have now been using it for almost five years and have gained a lot of experience. Over these past five years, we have learnt more and more about patient selection and aftercare. An increasing number of surgeons are taking an interest in this treatment method and offering it to „No-Option“ patients. 
We would like to thank the authors of this paper for the new insights. There is definitely more to come since we are only starting to scratch the surface of this new method! 🔬